Huanhuan Ma

1.1k total citations
30 papers, 694 citations indexed

About

Huanhuan Ma is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Huanhuan Ma has authored 30 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Cancer Research and 6 papers in Immunology. Recurrent topics in Huanhuan Ma's work include MicroRNA in disease regulation (5 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Insect Resistance and Genetics (4 papers). Huanhuan Ma is often cited by papers focused on MicroRNA in disease regulation (5 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Insect Resistance and Genetics (4 papers). Huanhuan Ma collaborates with scholars based in China, Hong Kong and United States. Huanhuan Ma's co-authors include Yidong Wu, Yihua Yang, Yayun Zuo, Qinxi Li, Wentao Zhao, Wenjie Lu, Donghai Lin, Furong Lin, Ai Chen and Jinyang Wang and has published in prestigious journals such as Journal of Biological Chemistry, Molecular Cell and Hepatology.

In The Last Decade

Huanhuan Ma

26 papers receiving 687 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huanhuan Ma China 12 514 178 172 86 78 30 694
April K. Marrone United States 16 414 0.8× 207 1.2× 29 0.2× 37 0.4× 18 0.2× 28 619
Isabel Pereira‐Castro Portugal 13 434 0.8× 114 0.6× 47 0.3× 40 0.5× 214 2.7× 25 796
Xianke Zeng United States 11 609 1.2× 119 0.7× 16 0.1× 52 0.6× 154 2.0× 13 816
Katsumi Kasashima Japan 14 772 1.5× 179 1.0× 43 0.3× 16 0.2× 28 0.4× 23 891
Federica Lo Sardo Italy 13 512 1.0× 154 0.9× 13 0.1× 73 0.8× 80 1.0× 18 769
Ziyou Cui United States 17 551 1.1× 44 0.2× 28 0.2× 22 0.3× 135 1.7× 26 782
Ming He China 16 615 1.2× 75 0.4× 24 0.1× 189 2.2× 46 0.6× 31 790
Cha Soon Kim South Korea 14 228 0.4× 67 0.4× 15 0.1× 57 0.7× 68 0.9× 28 564
Yongmei Li China 18 713 1.4× 384 2.2× 12 0.1× 40 0.5× 120 1.5× 45 986

Countries citing papers authored by Huanhuan Ma

Since Specialization
Citations

This map shows the geographic impact of Huanhuan Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huanhuan Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huanhuan Ma more than expected).

Fields of papers citing papers by Huanhuan Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huanhuan Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huanhuan Ma. The network helps show where Huanhuan Ma may publish in the future.

Co-authorship network of co-authors of Huanhuan Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Huanhuan Ma. A scholar is included among the top collaborators of Huanhuan Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huanhuan Ma. Huanhuan Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Huanhuan, Yao Lin, Bin Jiang, et al.. (2025). Nuclear Pirin promotes HCC by acting as a key inflammation-facilitating factor. Gut. gutjnl–2024. 1 indexed citations
3.
Zeng, Fanhong, Qingyang Zhang, Huanhuan Ma, et al.. (2025). Multimodal sequencing of neoadjuvant nivolumab treatment in hepatocellular carcinoma reveals cellular and molecular immune landscape for drug response. Molecular Cancer. 24(1). 110–110. 1 indexed citations
4.
Zou, Dan, et al.. (2025). The role of tissue factor in the tumor microenvironment and targeted therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1880(5). 189409–189409.
5.
Tsui, Yu‐Man, et al.. (2025). Lipid Metabolism and Immune Response in Hepatocellular Carcinoma: Interplay Driving Tumor Progression. The HKU Scholars Hub (University of Hong Kong).
6.
Li, Jing, Yiyong Wei, Yì Wáng, et al.. (2024). Metabolomics study of APETx2 post-conditioning on myocardial ischemia-reperfusion injury. Frontiers in Pharmacology. 15. 1470142–1470142.
7.
Tsui, Yu‐Man, et al.. (2024). Interplay among extracellular vesicles, cancer stemness and immune regulation in driving hepatocellular carcinoma progression. Cancer Letters. 597. 217084–217084. 3 indexed citations
8.
Ma, Huanhuan, et al.. (2024). Study on risk factors of carotid atherosclerosis in type 2 diabetes mellitus and development of prediction model. International Journal of Diabetes in Developing Countries. 45(1). 234–242. 2 indexed citations
9.
Li, J.G., Ye Cao, Yun Yang, et al.. (2023). Quantitative Acetylomics Reveals Substrates of Lysine Acetyltransferase GCN5 in Adult and Aging Drosophila. Journal of Proteome Research. 22(9). 2909–2924. 1 indexed citations
10.
Wang, Jinyang, Wentao Zhao, Yan Zhang, et al.. (2023). Hepatic conversion of acetyl-CoA to acetate plays crucial roles in energy stress. eLife. 12. 6 indexed citations
11.
Wang, Xiuli, Dongmei Zhang, Yu Pan, et al.. (2023). Pyrimidinergic receptor P2Y6 expression is elevated in lung adenocarcinoma and is associated with poor prognosis. Cancer Biomarkers. 38(2). 191–201. 4 indexed citations
12.
Jiang, Bin, Jia Zhang, Guohui Zhao, et al.. (2022). Filamentous GLS1 promotes ROS-induced apoptosis upon glutamine deprivation via insufficient asparagine synthesis. Molecular Cell. 82(10). 1821–1835.e6. 44 indexed citations
13.
Chen, Yuanyuan, Qian Wang, Huanhuan Ma, et al.. (2022). Diterpenoid alkaloids isolated from Delphinium trichophorum alleviate pulmonary fibrosis via the TGF-β/Smad pathway in 3T6 and HFL-1 cells. Biomedicine & Pharmacotherapy. 149. 112906–112906. 7 indexed citations
14.
Ma, Huanhuan, Lin Zhou, Mei‐Ling Cheng, et al.. (2021). c-Src facilitates tumorigenesis by phosphorylating and activating G6PD. Oncogene. 40(14). 2567–2580. 23 indexed citations
16.
Wu, Xiaofen, Kongyan Niu, Xiaofan Wang, et al.. (2021). microRNA-252 and FoxO repress inflammaging by a dual inhibitory mechanism on Dawdle-mediated TGF-β pathway inDrosophila. Genetics. 220(3). 3 indexed citations
17.
Wang, Jing, Huanhuan Ma, Shan Zhao, et al.. (2020). Functional redundancy of two ABC transporter proteins in mediating toxicity of Bacillus thuringiensis to cotton bollworm. PLoS Pathogens. 16(3). e1008427–e1008427. 80 indexed citations
18.
Ma, Huanhuan, Jia Zhang, Lin Zhou, et al.. (2020). c-Src Promotes Tumorigenesis and Tumor Progression by Activating PFKFB3. Cell Reports. 30(12). 4235–4249.e6. 51 indexed citations
19.
Zuo, Yayun, Wenjie Lu, Huanhuan Ma, et al.. (2020). Functional validation of nicotinic acetylcholine receptor (nAChR) α6 as a target of spinosyns in Spodoptera exigua utilizing the CRISPR/Cas9 system. Pest Management Science. 76(7). 2415–2422. 42 indexed citations
20.
Jiang, Bin, Wentao Zhao, Jia Zhang, et al.. (2018). IDH1 Arg-132 mutant promotes tumor formation through down-regulating p53. Journal of Biological Chemistry. 293(25). 9747–9758. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026